On Behalf Of The Dc Cohort Executive Committee
Biographic Data
| ID | 4553048 |
|---|---|
| NAME | On Behalf Of The Dc Cohort Executive Committee |
| GIVEN NAMES | On Behalf Of The Dc Cohort Executive |
| FAMILY NAME | Committee |
| SIGNATURE | COMMITTEE O B O T D C E |
| VERIFIED | No |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 6 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Comorbidities and treatment regimens of HIV-associated lipodystrophy disease among a cohort of persons with HIV in Washington, DC
HIV-associated lipodystrophy (HAL) continues to occur in persons with HIV (PWH) despite use of antiretroviral therapies (ART). The purpose of this study was to compare characteristics of PWH with and without HAL, determine associations between HAL diagnosis and medical comorbidities, describe correlates of HAL treatment and explore use of pre-HAL ART regimens among PWH in a large cohort. Using data from the DC Cohort longitudinal study of PWH in …
Prevalence and risk factors for post-Covid conditions of Covid-19 among persons with HIV in Washington, DC
Post-COVID conditions (long COVID) are defined as COVID symptoms persisting 28 days post-initial infection. The limited research available on the prevalence and experiences of post-COVID conditions among persons with HIV (PWH) indicates potential increased risk for post-COVID conditions. The purpose of this study was to characterize prevalence, symptom clustering, impact, and potential risk factors of post-COVID conditions among PWH. Data come fr…
Factors Influencing Successful Recruitment of Racial and Ethnic Minority Patients for an Observational HIV Cohort Study in Washington, DC
Diabetes mellitus control in a large cohort of people with HIV in care-Washington, D.C
With more effective antiretroviral therapy (ART), people with HIV (PWH) are living longer and have more chronic diseases, including diabetes mellitus (DM). The prevalence of DM has been estimated in PWH previously, however there is less research regarding DM control. Our objectives were to determine the prevalence of DM and DM control and determine factors associated with DM control in a large urban cohort of PWH in care. We examined DC Cohort pa…
Association of Substance Use Disorders with Engagement in Care and Mortality among a Clinical Cohort of People with HIV in Washington, DC
Despite early Medicaid expansion, decreased durable virologic suppression among publicly insured people with HIV in Washington, DC
Paradoxical differences between HIV monitoring and durable VS exist among publicly and privately-insured PWH in Washington, DC. Programs serving PWH must improve efforts to address barriers creating inequity in HIV outcomes
No prominent works on this page.
Despite early Medicaid expansion, decreased durable virologic suppression among publicly insured people with HIV in Washington, DC
Paradoxical differences between HIV monitoring and durable VS exist among publicly and privately-insured PWH in Washington, DC. Programs serving PWH must improve efforts to address barriers creating inequity in HIV outcomes
Diabetes mellitus control in a large cohort of people with HIV in care-Washington, D.C
With more effective antiretroviral therapy (ART), people with HIV (PWH) are living longer and have more chronic diseases, including diabetes mellitus (DM). The prevalence of DM has been estimated in PWH previously, however there is less research regarding DM control. Our objectives were to determine the prevalence of DM and DM control and determine factors associated with DM control in a large urban cohort of PWH in care. We examined DC Cohort pa…
Association of Substance Use Disorders with Engagement in Care and Mortality among a Clinical Cohort of People with HIV in Washington, DC
Factors Influencing Successful Recruitment of Racial and Ethnic Minority Patients for an Observational HIV Cohort Study in Washington, DC
Prevalence and risk factors for post-Covid conditions of Covid-19 among persons with HIV in Washington, DC
Post-COVID conditions (long COVID) are defined as COVID symptoms persisting 28 days post-initial infection. The limited research available on the prevalence and experiences of post-COVID conditions among persons with HIV (PWH) indicates potential increased risk for post-COVID conditions. The purpose of this study was to characterize prevalence, symptom clustering, impact, and potential risk factors of post-COVID conditions among PWH. Data come fr…
Comorbidities and treatment regimens of HIV-associated lipodystrophy disease among a cohort of persons with HIV in Washington, DC
HIV-associated lipodystrophy (HAL) continues to occur in persons with HIV (PWH) despite use of antiretroviral therapies (ART). The purpose of this study was to compare characteristics of PWH with and without HAL, determine associations between HAL diagnosis and medical comorbidities, describe correlates of HAL treatment and explore use of pre-HAL ART regimens among PWH in a large cohort. Using data from the DC Cohort longitudinal study of PWH in …
Medicine (5 works) · Cohort (4 works) · Cohort study (4 works) · Demography (4 works) · HIV/AIDS Research and Interventions (4 works) · Internal Medicine (4 works) · Gerontology (3 works) · Logistic regression (3 works) · Family medicine (2 works) · Health care (2 works)